Feed JBS
JB

Jbs N.V. JBS · NYSE

$12.91 -0.96% (-$0.13)

Summary

59 / 100 · Bulios Score

What speaks for it

  • Earnings per share grew by 14% a year over the last 3 years.
  • It earns 37 BRL a year on every 100 BRL of invested capital.
  • The share price is below the Bulios Fair Price.

What to watch

  • It pays out more in dividends than it earns: 174% of profit.
  • Out of every 100 BRL of revenue, only 1.7 BRL is left as net profit.
  • Operating profit covers the interest on its debt only 2.7 times.
  • It missed profit estimates 3 times in the last 6 quarters.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks cheap
Bulios Fair Price
Current price $12.91
Packaged Foods industry median
P/E today 22.5

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 22.5 BRL for 1 BRL of yearly profit.

Valuation in detail

Is it growing?

Yes, fast

Revenue (BRL)

Diluted EPS (BRL)

  • Analyst estimate

Revenue grew by 12% a year over 5 years. Over the last 3 years it grew by 7.1% a year. For the next fiscal year analysts expect revenue to grow by 2.9%. Earnings per share grew by 14% a year over the last 3 years.

Growth in detail

Does it make money?

Poorly

Where 100 BRL of revenue goes

Net profit, industry median (Packaged Foods) 5.7 BRL

Out of every 100 BRL of revenue, 1.7 BRL is left as net profit.

Profitability in detail

Is it financially healthy?

Debt is a burden

Repaying all its debt would take 7.8 years of free cash flow. Its debt is larger than its cash.

Financial health in detail

Does it pay a dividend?

High, at risk
Yield
7.75%
Paid out of profit
174%

You receive $1.00 per share a year. The payout is more than the company can comfortably cover.

Dividends in detail

What do analysts expect?

Mildly positive

Today's price within the analysts' price targets

The average target of $18.17 is 41% above today's price. 100% of the analysts recommend buying.

Analysts in detail

What does it earn on?

Fiscal year 2025

By product

The company reports no revenue by product.

By region

South America brings in 63% of revenue.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.